Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Anemia, Aplastic"" wg kryterium: Temat


Starter badań:

Tytuł :
Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia working party of the European Society for blood and marrow transplantation (SAAWP of EBMT).
Autorzy :
Iftikhar R; Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan. .
Ahmad P; Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan.
de Latour R; Saint-Louis Hospital, Paris, France.
Dufour C; G Gaslini Children Research Hospital, Genova, Italy.
Risitano A; AORN Moscati, Avellino, Italy.; Federico II University, Naples, Italy.
Chaudhri N; King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Bazarbachi A; American University of Beirut Medical Center, Beirut, Lebanon.
De La Fuente J; Imperial College, London, United Kingdom.
Höchsmann B; University Hospital Ulm, Ulm, Germany.
Osman Ahmed S; King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Gergis U; Sidney Kimmel Cancer Center, Philadelphia, PA, USA.
Elhaddad A; National Cancer Institute, Cairo University, Cairo, Egypt.
Halkes C; Leiden University Medical Centre, Leiden, The Netherlands.
Albeirouti B; King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia.
Alotaibi S; Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Kulasekararaj A; King's College Hospital, London, United Kingdom.
Alzahrani H; King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Ben Othman T; Center National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.
Cesaro S; Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Alahmari A; King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Rihani R; King Hussein Cancer Center, Amman, Jordan.
Alshemmari S; Faculty of Medicine, Kuwait University, Jabriya, Kuwait.
Ali Hamidieh A; Pediatric Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Bekadja MA; University Hospital Establishment, Oran, Algeria.
Passweg J; University Hospital Basel, Basel, Switzerland.
Al-Khabori M; Sultan Qaboos University, Muscat, Oman.
Rasheed W; King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Bacigalupo A; Universita' Cattolica del Sacro Cuore, Roma, Italy.
Chaudhry QU; Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan.
Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Division of Hematology Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Marsh J; King's College Hospital, London, United Kingdom.
El Fakih R; King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Aljurf M; King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Pokaż więcej
Corporate Authors :
Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group
Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP of EBMT)
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Oct; Vol. 56 (10), pp. 2518-2532. Date of Electronic Publication: 2021 May 19.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anemia, Aplastic*/diagnosis
Anemia, Aplastic*/therapy
Hematopoietic Stem Cell Transplantation*
Bone Marrow ; Bone Marrow Failure Disorders ; Bone Marrow Transplantation ; Humans ; Transplantation Conditioning
Czasopismo naukowe
Tytuł :
Rapid blood cell recovery with immunosuppressive therapy combined with romiplostim in a patient with very severe hepatitis-associated aplastic anemia who underwent liver transplantation.
Autorzy :
Yoshinari H; Department of Pediatrics, Jichi Medical University School of Medicine, 3311-1, Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
Kawahara Y; Department of Pediatrics, Jichi Medical University School of Medicine, 3311-1, Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan. .
Niijima H; Department of Pediatrics, Jichi Medical University School of Medicine, 3311-1, Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
Oh Y; Department of Pediatrics, Jichi Medical University School of Medicine, 3311-1, Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
Hirata Y; Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichi Medical University, Shimotsuke, Japan.
Okada N; Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichi Medical University, Shimotsuke, Japan.
Sanada Y; Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichi Medical University, Shimotsuke, Japan.
Onishi Y; Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichi Medical University, Shimotsuke, Japan.
Sakuma Y; Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichi Medical University, Shimotsuke, Japan.
Morimoto A; Department of Pediatrics, Jichi Medical University School of Medicine, 3311-1, Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2021 Oct; Vol. 114 (4), pp. 524-527. Date of Electronic Publication: 2021 Jun 10.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Liver Transplantation*/adverse effects
Liver Transplantation*/methods
Anemia, Aplastic/*drug therapy
Anemia, Aplastic/*etiology
Hepatitis/*complications
Hepatitis/*surgery
Receptors, Fc/*administration & dosage
Recombinant Fusion Proteins/*administration & dosage
Thrombopoietin/*administration & dosage
Anemia, Aplastic/blood ; Blood Cell Count ; Child ; Disease Management ; Disease Susceptibility ; Female ; Hepatitis/diagnosis ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.
Autorzy :
Shah YB; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA.
Priore SF; Division of Precision and Computational Diagnostics, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
Li Y; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Tang CN; Division of Precision and Computational Diagnostics, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
Nicholas P; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA.
Kurre P; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA.
Olson TS; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA.; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; and.
Babushok DV; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA.; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
Pokaż więcej
Źródło :
Blood advances [Blood Adv] 2021 Aug 24; Vol. 5 (16), pp. 3216-3226.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Anemia, Aplastic*/diagnosis
Anemia, Aplastic*/genetics
Hemoglobinuria, Paroxysmal*/diagnosis
Hemoglobinuria, Paroxysmal*/genetics
Bayes Theorem ; Child ; Clone Cells ; Gene Rearrangement ; Humans
Czasopismo naukowe
Tytuł :
Severe Seronegative Hepatitis-associated Aplastic Anemia: Looking for the Best Treatment.
Autorzy :
Kemme S; Section of Gastroenterology, Hepatology and Nutrition, and the Digestive Health Institute, Children's Hospital Colorado, University of Colorado Denver School of Medicine, CO.
Feldman AG
Mack C
Pokaż więcej
Źródło :
Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2021 Aug 01; Vol. 73 (2), pp. e48.
Typ publikacji :
Journal Article
MeSH Terms :
Anemia, Aplastic*/complications
Anemia, Aplastic*/diagnosis
Anemia, Aplastic*/therapy
Hepatitis*/complications
Hepatitis*/diagnosis
Humans ; Immunosuppressive Agents/therapeutic use
Czasopismo naukowe
Tytuł :
Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia.
Autorzy :
Yang W; State Key Laboratory of Experimental Hematology, Department of Anemia Therapeutic Center, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Zhao X; State Key Laboratory of Experimental Hematology, Department of Anemia Therapeutic Center, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Peng G; State Key Laboratory of Experimental Hematology, Department of Anemia Therapeutic Center, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Zhang L; State Key Laboratory of Experimental Hematology, Department of Anemia Therapeutic Center, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Jing L; State Key Laboratory of Experimental Hematology, Department of Anemia Therapeutic Center, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Zhou K; State Key Laboratory of Experimental Hematology, Department of Anemia Therapeutic Center, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Li Y; State Key Laboratory of Experimental Hematology, Department of Anemia Therapeutic Center, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Ye L; State Key Laboratory of Experimental Hematology, Department of Anemia Therapeutic Center, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Li Y; State Key Laboratory of Experimental Hematology, Department of Anemia Therapeutic Center, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Li J; State Key Laboratory of Experimental Hematology, Department of Anemia Therapeutic Center, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Fan H; State Key Laboratory of Experimental Hematology, Department of Anemia Therapeutic Center, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Yang Y; State Key Laboratory of Experimental Hematology, Department of Anemia Therapeutic Center, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Zhang F; State Key Laboratory of Experimental Hematology, Department of Anemia Therapeutic Center, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Oct; Vol. 100 (10), pp. 2435-2441. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoiesis*
Anemia, Aplastic/*etiology
Hemoglobinuria, Paroxysmal/*complications
Hepatitis/*complications
Adolescent ; Adult ; Anemia, Aplastic/pathology ; Child ; Child, Preschool ; Clone Cells/pathology ; Erythrocytes/pathology ; Female ; Granulocytes/pathology ; Hemoglobinuria, Paroxysmal/pathology ; Hepatitis/pathology ; Humans ; Male ; Middle Aged ; Young Adult
SCR Disease Name :
Aplastic anemia, idiopathic
Czasopismo naukowe
Tytuł :
Recurrent secondary graft failure likely due to a DRB4 donor-specific antibody in a patient with aplastic anemia and DRB4 null allele.
Autorzy :
Blennerhassett R; Department of Haematology, St Vincent's Hospital, Sydney, NSW, Australia. .; University of New South Wales, Medical School, Sydney, NSW, Australia. .
Moses JH; Australian Red Cross LifeBlood, NSW Transplantation and Immunogenetics Service, Sydney, NSW, Australia.
Coulits N; Australian Red Cross LifeBlood, NSW Transplantation and Immunogenetics Service, Sydney, NSW, Australia.
Horne A; Department of Haematology, St Vincent's Hospital, Sydney, NSW, Australia.
Simpson J; Mid North Coast Haematology, Macquarie, NSW, Australia.
Marshall J; Australian Red Cross LifeBlood, NSW Transplantation and Immunogenetics Service, Sydney, NSW, Australia.
Weston L; Australian Red Cross LifeBlood, NSW Transplantation and Immunogenetics Service, Sydney, NSW, Australia.
Moore J; Department of Haematology, St Vincent's Hospital, Sydney, NSW, Australia.; University of New South Wales, Medical School, Sydney, NSW, Australia.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Oct; Vol. 56 (10), pp. 2603-2605. Date of Electronic Publication: 2021 Jul 07.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Anemia, Aplastic*/therapy
Graft vs Host Disease*
Alleles ; HLA-DRB1 Chains ; HLA-DRB4 Chains ; Humans ; Tissue Donors
Raport
Tytuł :
Full Dose Cyclophosphamide with the Addition of Fludarabine for Matched Sibling Transplants in Severe Aplastic Anemia.
Autorzy :
El Fakih R; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Electronic address: .
Alhayli S; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Ahmed SO; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Shaheen M; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Chaudhri N; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Alsharif F; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Hanbali A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Alfraih F; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Alshaibani A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Assiri A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Samarkandi H; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Babiker F; Department of Medicine, Alfaisal University School of Medicine, Riyadh, Saudi Arabia.
Alshomar A; Department of Medicine, College of Medicine, Qassim University, Buraydah, Saudi Arabia.
Alhakim A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Ghabashi E; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Kotb A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Elhassan T; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Balbaid A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Alsadi H; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Rasheed W; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Alahmari A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Alzahrani H; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Almohareb F; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Aljurf M; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło :
Transplantation and cellular therapy [Transplant Cell Ther] 2021 Oct; Vol. 27 (10), pp. 851.e1-851.e6. Date of Electronic Publication: 2021 Jun 12.
Typ publikacji :
Journal Article
MeSH Terms :
Anemia, Aplastic*/therapy
Adult ; Cyclophosphamide/therapeutic use ; Humans ; Prospective Studies ; Retrospective Studies ; Siblings ; Vidarabine/analogs & derivatives
Czasopismo naukowe
Tytuł :
Outcomes of severe aplastic anemia patients with infection proceeding with allogeneic hematopoietic stem cell transplantation, versus patients without infection.
Autorzy :
Liu L; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
Miao M; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
Chen X; Department of Hematology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Zhang Y; Department of Hematology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, China.
Lei M; Department of Hematology in Haikou Municipal People's Hospital, Affiliated Haikou Hospital Xiangya School of Medicine Central South University, Haikou, Hainan, China.
Li B; Department of Hematology, Children's Hospital of Soochow University, Suzhou, China.
Zhou H; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
Wang Q; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
Qiu H; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
Tang X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
Han Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
Fu C; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
Jin Z; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
Chen S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
Sun A; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
Wang S; Department of Hematology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China. .
Wu D; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Oct; Vol. 56 (10), pp. 2591-2594. Date of Electronic Publication: 2021 Jul 03.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Anemia, Aplastic*/therapy
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Humans ; Transplantation Conditioning ; Transplantation, Homologous ; Treatment Outcome
Raport
Tytuł :
Secondary malignancies after transplantation for aplastic anemia.
Autorzy :
Socié G; Université de Paris, INSERM U976, Paris, France. .; Hematology Transplantation, AP-HP Saint Louis Hôpital, Paris, France. .
Peffault de Latour R; Hematology Transplantation, AP-HP Saint Louis Hôpital, Paris, France.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Oct; Vol. 56 (10), pp. 2324-2325. Date of Electronic Publication: 2021 Jul 07.
Typ publikacji :
Editorial
MeSH Terms :
Anemia, Aplastic*/therapy
Neoplasms*
Bone Marrow Transplantation ; Humans ; Transplantation, Homologous
Opinia redakcyjna
Tytuł :
Detection and treatment of cerebral toxoplasmosis in an aplastic pediatric post-allogeneic hematopoietic cell transplant patient: a case report.
Autorzy :
Brewer D; Medical School, University of Minnesota, Minneapolis, MN, USA.
MacMillan ML; Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapy, University of Minnesota, Minneapolis, MN, USA.
Schleiss MR; Department of Pediatrics, Division of Infectious Diseases, University of Minnesota, Minneapolis, MN, USA.
Ayuthaya SIN; Department of Pediatrics, Division of Infectious Diseases, University of Minnesota, Minneapolis, MN, USA.
Young JA; Department of Medicine, Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, MN, USA.
Ebens CL; Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapy, University of Minnesota, Minneapolis, MN, USA. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Sep 10; Vol. 21 (1), pp. 941. Date of Electronic Publication: 2021 Sep 10.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Anemia, Aplastic*/therapy
Hematopoietic Stem Cell Transplantation*/adverse effects
Opportunistic Infections*
Toxoplasmosis, Cerebral*/diagnosis
Toxoplasmosis, Cerebral*/drug therapy
Child ; Humans ; Transplantation, Homologous/adverse effects
Czasopismo naukowe
Tytuł :
A novel TBI free conditioning protocol for haploidentical transplant in acquired aplastic anemia: (FluCAB-Prime).
Autorzy :
Iftikhar R; Department of Hematology and Stem Cell Transplant, Armed forces Bone Marrow Transplant Center/National Institute of Blood and Marrow Transplant, Rawalpindi, Pakistan. .
Chaudhry QN; Department of Hematology and Stem Cell Transplant, Armed forces Bone Marrow Transplant Center/National Institute of Blood and Marrow Transplant, Rawalpindi, Pakistan.
Mahmood SK; Department of Hematology and Stem Cell Transplant, Armed forces Bone Marrow Transplant Center/National Institute of Blood and Marrow Transplant, Rawalpindi, Pakistan.
Ghafoor T; Department of Hematology and Stem Cell Transplant, Armed forces Bone Marrow Transplant Center/National Institute of Blood and Marrow Transplant, Rawalpindi, Pakistan.
Shahbaz N; Department of Hematology and Stem Cell Transplant, Armed forces Bone Marrow Transplant Center/National Institute of Blood and Marrow Transplant, Rawalpindi, Pakistan.
Khan MA; Department of Hematology and Stem Cell Transplant, Armed forces Bone Marrow Transplant Center/National Institute of Blood and Marrow Transplant, Rawalpindi, Pakistan.
Khattak TA; Department of Hematology and Stem Cell Transplant, Armed forces Bone Marrow Transplant Center/National Institute of Blood and Marrow Transplant, Rawalpindi, Pakistan.
Shamshad GU; Department of Hematology and Stem Cell Transplant, Armed forces Bone Marrow Transplant Center/National Institute of Blood and Marrow Transplant, Rawalpindi, Pakistan.
Rehman J; Department of Hematology and Stem Cell Transplant, Armed forces Bone Marrow Transplant Center/National Institute of Blood and Marrow Transplant, Rawalpindi, Pakistan.
Farhan M; Department of Hematology and Stem Cell Transplant, Armed forces Bone Marrow Transplant Center/National Institute of Blood and Marrow Transplant, Rawalpindi, Pakistan.
Satti TM; Shifa International Hospital, Islamabad, Pakistan.
Ahmed P; Department of Hematology Oncology and Stem Cell Transplant, Quaid-e-Azam International Hospital, Islamabad, Pakistan.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Sep; Vol. 56 (9), pp. 2309-2311. Date of Electronic Publication: 2021 Jun 25.
Typ publikacji :
Letter
MeSH Terms :
Anemia, Aplastic*/therapy
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Humans ; Transplantation Conditioning ; Transplantation, Haploidentical
Opinia redakcyjna
Tytuł :
Successful haploidentical transplantation using plasma exchange and post-transplantation cyclophosphamide for severe aplastic anemia patients with anti-human leukocyte antigen donor-specific antibodies.
Autorzy :
Cao J; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China. .; Departmentof Hematology, Yinzhou People's Hospital, 251 Baizhang Road, Ningbo, 315040, Zhejiang Province, China. .
Pei R; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China.
Zhang P; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China.
Liu X; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China.
Chen D; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China.
Du X; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China.
Chen L; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China.
Wang T; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China.
Ye P; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China.
Lu Y; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Sep; Vol. 100 (9), pp. 2381-2385. Date of Electronic Publication: 2021 Jul 06.
Typ publikacji :
Journal Article
MeSH Terms :
Anemia, Aplastic/*therapy
Cyclophosphamide/*therapeutic use
Hematopoietic Stem Cell Transplantation/*methods
Immunosuppressive Agents/*therapeutic use
Plasma Exchange/*methods
Transplantation, Haploidentical/*methods
Adult ; Anemia, Aplastic/immunology ; Antibodies/immunology ; Female ; HLA Antigens/immunology ; Humans ; Male ; Middle Aged ; Tissue Donors
Czasopismo naukowe
Tytuł :
Research advances on haploidentical hematopoietic stem cell transplantation in the treatment of severe aplastic anemia in children.
Autorzy :
Gao YY; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Chen XJ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Luo RM
Pokaż więcej
Transliterated Title :
单倍体造血干细胞移植治疗儿童重型再生障碍性贫血的研究进展.
Źródło :
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics [Zhongguo Dang Dai Er Ke Za Zhi] 2021 Aug 15; Vol. 23 (8), pp. 854-859.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anemia, Aplastic*/therapy
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Child ; Humans ; Transplantation Conditioning ; Transplantation, Homologous
Czasopismo naukowe
Tytuł :
[Expression and Significance of BLIMP-1 in Regulatory T Cells of Children with Aplastic Anemia].
Autorzy :
Huang LF; Department of Pediatrics,The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, Guangdong Province, China.
Huang JB; Department of Pediatrics, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, Guangdong Province, China.
Tang NN; Department of Pediatrics, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, Guangdong Province, China.
Xue HM; Department of Pediatrics, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, Guangdong Province, China.
Zhu CM; Scientific Research Center, 2Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, Guangdong Province, China.
Li CK; Division of Hematology/Oncology/BMT, Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong 999077, China.
Chen C; Department of Pediatrics, 2Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, Guangdong Province, China,E-mail: .
Pokaż więcej
Źródło :
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2021 Aug; Vol. 29 (4), pp. 1251-1256.
Typ publikacji :
Journal Article
MeSH Terms :
Anemia, Aplastic*
T-Lymphocytes, Regulatory*
Child ; Cytokines ; Flow Cytometry ; Forkhead Transcription Factors ; Humans ; Positive Regulatory Domain I-Binding Factor 1 ; Transforming Growth Factor beta
Czasopismo naukowe
Tytuł :
Seronegative Autoimmune Hepatitis-associated Severe Aplastic Anemia: Looking for the Best Treatment.
Autorzy :
Maggiore G; Division of Hepatogastroenterology, Nutrition and Liver Transplant, IRCCS Bambino Gesù Pediatric Hospital, Rome.
Pietrobattista A; Division of Hepatogastroenterology, Nutrition and Liver Transplant, IRCCS Bambino Gesù Pediatric Hospital, Rome.
Liccardo D; Division of Hepatogastroenterology, Nutrition and Liver Transplant, IRCCS Bambino Gesù Pediatric Hospital, Rome.
Sciveres M; Pediatric Hepatology and Liver Transplant, ISMETT, University of Pittsburg Medical Center, Palermo, Italy.
Nastasio S; Department of Pediatrics, Harvard Medical School, Boston's Children Hospital, MA.
Jacquemin E; Pediatric Hepatology and Pediatric Liver Transplantation Unit, National Reference Center for Rare Pediatric Liver Diseases and Filfoie, Hopital Bicêtre, Assistance Publique-Hopitaux de Paris, Le Kremlin-Bicêtre.; University Paris-sud/Paris-Saclay and INSERM UMR-S1174 and Hepatinov, Orsay, France.
Bernard O; Pediatric Hepatology and Pediatric Liver Transplantation Unit, National Reference Center for Rare Pediatric Liver Diseases and Filfoie, Hopital Bicêtre, Assistance Publique-Hopitaux de Paris, Le Kremlin-Bicêtre.
Pokaż więcej
Źródło :
Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2021 Aug 01; Vol. 73 (2), pp. e48.
Typ publikacji :
Journal Article
MeSH Terms :
Anemia, Aplastic*/therapy
Hepatitis*
Hepatitis, Autoimmune*/complications
Hepatitis, Autoimmune*/diagnosis
Hepatitis, Autoimmune*/drug therapy
Humans ; Immunosuppressive Agents/therapeutic use
Czasopismo naukowe
Tytuł :
Has Eltrombopag eliminated the need to use allogeneic HSCT in first line treatment of pediatric aplastic anemia?
Autorzy :
Huan Ng C; Division of Pediatric Hematology, Oncology and BMT, Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Jang-Milligan F; School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Schultz KR; Division of Pediatric Hematology, Oncology and BMT, Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Pokaż więcej
Źródło :
Pediatric hematology and oncology [Pediatr Hematol Oncol] 2021 Aug; Vol. 38 (5), pp. 417-419. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji :
Journal Article; Review; Video-Audio Media
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Anemia, Aplastic/*therapy
Benzoates/*administration & dosage
Hydrazines/*administration & dosage
Pyrazoles/*administration & dosage
Allografts ; Anemia, Aplastic/mortality ; Benzoates/adverse effects ; Child ; Female ; Humans ; Hydrazines/adverse effects ; Male ; Pyrazoles/adverse effects
Czasopismo naukowe
Tytuł :
Germline variants drive myelodysplastic syndrome in young adults.
Autorzy :
Feurstein S; Department of Medicine, Section of Hematology/Oncology, The University of Chicago Comprehensive Cancer Center, The University of Chicago, Chicago, IL, USA.
Churpek JE; Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, The University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Walsh T; Department of Medicine, Division of Medical Genetics, University of Washington, Seattle, WA, USA.
Keel S; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
Hakkarainen M; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland.
Schroeder T; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany.
Germing U; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany.
Geyh S; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany.
Heuser M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Thol F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Pohlkamp C; Munich Leukemia Laboratory, Munich, Germany.
Haferlach T; Munich Leukemia Laboratory, Munich, Germany.
Gao J; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Owen C; Division of Hematology and Hematological Malignancies, University of Calgary, Calgary, AB, Canada.
Goehring G; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
Schlegelberger B; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
Verma D; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Medicine, Frankfurt, Germany.; Department of Medicine, Albert Einstein College of Medicine, New York, NY, USA.
Krause DS; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Medicine, Frankfurt, Germany.
Gao G; Department of Public Health Sciences, The University of Chicago, Chicago, IL, USA.
Cronin T; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Gulsuner S; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Lee M; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Pritchard CC; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
Subramanian HP; Department of Human Genetics, The University of Chicago, Chicago, IL, USA.
Del Gaudio D; Department of Human Genetics, The University of Chicago, Chicago, IL, USA.
Li Z; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute and Houston Methodist Hospital, Houston, TX, USA.
Das S; Department of Human Genetics, The University of Chicago, Chicago, IL, USA.
Kilpivaara O; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Medical and Clinical Genetics/Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Wartiovaara-Kautto U; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland.
Wang ES; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
King MC; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Godley LA; Department of Medicine, Section of Hematology/Oncology, The University of Chicago Comprehensive Cancer Center, The University of Chicago, Chicago, IL, USA. .
Pokaż więcej
Źródło :
Leukemia [Leukemia] 2021 Aug; Vol. 35 (8), pp. 2439-2444. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji :
Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Genetic Predisposition to Disease*
Germ-Line Mutation*
Anemia, Aplastic/*genetics
Biomarkers/*analysis
Myelodysplastic Syndromes/*genetics
Adolescent ; Adult ; Anemia, Aplastic/pathology ; Female ; Humans ; Male ; Myelodysplastic Syndromes/pathology ; Prognosis ; Young Adult
Raport
Tytuł :
[Analysis of the Outcome and Prognostic Factors of Cyclosporine A in Children with Non-severe Aplastic Anemia].
Autorzy :
Lu WJ; Department of Hematological Oncology, Wuhan Children's Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430016, Hubei Province, China.
Zhang L; Department of Hematological Oncology, Wuhan Children's Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430016, Hubei Province, China.
Yang L; Department of Hematological Oncology, Wuhan Children's Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430016, Hubei Province, China.
Wang Z; Department of Hematological Oncology, Wuhan Children's Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430016, Hubei Province, China.
Nie YM; Department of Hematological Oncology, Wuhan Children's Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430016, Hubei Province, China.
Chen Z; Department of Hematological Oncology, Wuhan Children's Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430016, Hubei Province, China.
Li H; Department of Hematological Oncology, Wuhan Children's Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430016, Hubei Province, China.
Li JX; Department of Hematological Oncology, Wuhan Children's Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430016, Hubei Province, China.
Xiong H; Department of Hematological Oncology, Wuhan Children's Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430016, Hubei Province, China,E-mail: .
Pokaż więcej
Źródło :
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2021 Aug; Vol. 29 (4), pp. 1257-1261.
Typ publikacji :
Journal Article
MeSH Terms :
Anemia, Aplastic*/drug therapy
Cyclosporine*
Child ; Child, Preschool ; Female ; Humans ; Immunosuppressive Agents ; Male ; Prognosis ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Decreased bone marrow regulatory innate lymphoid cells show a distinctive miRNA profiling in aplastic anemia.
Autorzy :
Li Y; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Wan D; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Guo R; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Wang F; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Han L; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Zhang D; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Xing H; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Cao W; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Liu Y; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Xie X; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Yu J; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.; Department of Oncology, Academy of Medical and Pharmaceutical Sciences of Zhengzhou University, Zhengzhou, People's Republic of China.
Jiang Z; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Pokaż więcej
Źródło :
Hematology (Amsterdam, Netherlands) [Hematology] 2021 Dec; Vol. 26 (1), pp. 37-42.
Typ publikacji :
Journal Article
MeSH Terms :
Anemia, Aplastic/*genetics
Bone Marrow/*pathology
Lymphocytes/*pathology
MicroRNAs/*genetics
Adult ; Aged ; Anemia, Aplastic/immunology ; Anemia, Aplastic/pathology ; Bone Marrow/immunology ; Bone Marrow/metabolism ; Down-Regulation ; Female ; Humans ; Immunity, Innate ; Lymphocytes/immunology ; Lymphocytes/metabolism ; Male ; MicroRNAs/immunology ; Middle Aged ; Transcriptome ; Up-Regulation ; Young Adult
Czasopismo naukowe
Tytuł :
Mixed chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia.
Autorzy :
Zhang Y; Department of Hematology, Nansha Hospital, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Li Y; Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Wu L; Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Zhou M; Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Wang C; Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Mo W; Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Chen X; Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Xu S; Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Zhou R; Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Wang S; Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Zhang Y; Department of Hematology, Nansha Hospital, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Pokaż więcej
Źródło :
Hematology (Amsterdam, Netherlands) [Hematology] 2021 Dec; Vol. 26 (1), pp. 435-443.
Typ publikacji :
Journal Article
MeSH Terms :
Chimerism*
Hematopoietic Stem Cell Transplantation*/adverse effects
Anemia, Aplastic/*therapy
Adult ; Anemia, Aplastic/diagnosis ; Anemia, Aplastic/genetics ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Transplantation, Homologous/adverse effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies